{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T09:10:55Z","timestamp":1777540255033,"version":"3.51.4"},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.nano.2013.10.002","type":"journal-article","created":{"date-parts":[[2013,10,15]],"date-time":"2013-10-15T01:15:33Z","timestamp":1381799733000},"page":"609-618","source":"Crossref","is-referenced-by-count":45,"title":["Synergistic activity profile of carbosilane dendrimer G2-STE16 in combination with other dendrimers and antiretrovirals as topical anti-HIV-1 microbicide"],"prefix":"10.1016","volume":"10","author":[{"given":"Daniel","family":"Sep\u00falveda-Crespo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel","family":"Lorente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Leal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco J.","family":"De la Mata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Luis","family":"Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00aa \u00c1ngeles","family":"Mu\u00f1oz-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2013.10.002_bb0005","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1742-4690-8-65","article-title":"The utility of the new generation of humanized mice to study HIV-1 infection: transmission, prevention, pathogenesis, and treatment","volume":"8","author":"Berges","year":"2011","journal-title":"Retrovirology"},{"key":"10.1016\/j.nano.2013.10.002_bb0010","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0140-6736(06)69157-5","article-title":"HIV\/AIDS epidemiology, pathogenesis, prevention, and treatment","volume":"368","author":"Simon","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.nano.2013.10.002_bb0255","series-title":"Global report: UNAIDS Report on the global AIDS epidemic 2012","year":"2012"},{"key":"10.1016\/j.nano.2013.10.002_bb0020","doi-asserted-by":"crossref","first-page":"e50529","DOI":"10.1371\/journal.pone.0050529","article-title":"Evaluation of TLR agonists as potential mucosal adjuvants for HIV gp140 and tetanus toxoid in mice","volume":"7","author":"Buffa","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.nano.2013.10.002_bb0025","doi-asserted-by":"crossref","first-page":"4310","DOI":"10.1016\/j.vaccine.2011.11.014","article-title":"HIV vaccine development: challenges and opportunities towards solving the HIV vaccine-neutralizing antibody problem","volume":"30","author":"Koff","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.nano.2013.10.002_bb0030","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.tim.2012.05.005","article-title":"Microbicides: still a long road to success","volume":"20","author":"Vanpouille","year":"2012","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.nano.2013.10.002_bb0035","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.antiviral.2012.09.015","article-title":"Development and evaluation of a thermosensitive vaginal gel containing raltegravir+efavirenz loaded nanoparticles for HIV prophylaxis","volume":"96","author":"Date","year":"2012","journal-title":"Antivir Res"},{"key":"10.1016\/j.nano.2013.10.002_bb0040","doi-asserted-by":"crossref","first-page":"a007385","DOI":"10.1101\/cshperspect.a007385","article-title":"Microbicides: topical prevention against HIV","volume":"2","author":"Shattock","year":"2012","journal-title":"Cold Spring Harbor Perspect Med"},{"key":"10.1016\/j.nano.2013.10.002_bb0045","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1473-3099(08)70254-8","article-title":"Vaginal microbicides and the prevention of HIV transmission","volume":"8","author":"Cutler","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.nano.2013.10.002_bb0050","first-page":"561","article-title":"VivaGel (SPL7013 Gel): a candidate dendrimer\u2013microbicide for the prevention of HIV and HSV infection","volume":"2","author":"Rupp","year":"2007","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2013.10.002_bb0055","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.bpobgyn.2012.01.010","article-title":"Overview of microbicides for the prevention of human immunodeficiency virus","volume":"26","author":"Abdool Karim","year":"2012","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.nano.2013.10.002_bb0060","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1128\/AAC.00891-09","article-title":"Ex vivo comparison of microbicide efficacies for preventing HIV-1 genomic integration in intraepithelial vaginal cells","volume":"54","author":"McElrath","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl. 1","key":"10.1016\/j.nano.2013.10.002_bb0065","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.antiviral.2010.09.011","article-title":"Preventing mucosal HIV transmission with topical microbicides: challenges and opportunities","volume":"88","author":"Hladik","year":"2010","journal-title":"Antiviral Res"},{"key":"10.1016\/j.nano.2013.10.002_bb0070","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.bpobgyn.2012.02.002","article-title":"Vaginal microbicides to prevent human immunodeficiency virus infection in women: perspectives on the female genital tract, sexual maturity and mucosal inflammation","volume":"26","author":"Roberts","year":"2012","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"Suppl. 1","key":"10.1016\/j.nano.2013.10.002_bb0075","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.antiviral.2010.09.018","article-title":"Preclinical evaluation of anti-HIV microbicide products: new models and biomarkers","volume":"88","author":"Doncel","year":"2010","journal-title":"Antivir Res"},{"key":"10.1016\/j.nano.2013.10.002_bb0080","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0140-6736(07)60202-5","article-title":"Microbicide drug candidates to prevent HIV infection","volume":"369","author":"Balzarini","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.nano.2013.10.002_bb0085","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.antiviral.2011.03.188","article-title":"Synergistic in vitro anti-HIV type 1 activity of tenofovir with carbohydrate-binding agents (CBAs)","volume":"90","author":"Ferir","year":"2011","journal-title":"Antivir Res"},{"key":"10.1016\/j.nano.2013.10.002_bb0090","doi-asserted-by":"crossref","first-page":"4984","DOI":"10.2174\/0929867311209024984","article-title":"Antiviral properties against HIV of water soluble copper carbosilane dendrimers and their EPR characterization","volume":"19","author":"Galan","year":"2012","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.nano.2013.10.002_bb0095","doi-asserted-by":"crossref","first-page":"5874","DOI":"10.1039\/c3dt32870h","article-title":"Anionic sulfonated and carboxylated PPI dendrimers with the EDA core: synthesis and characterization of selective metal complexing agents","volume":"42","author":"Garcia-Gallego","year":"2013","journal-title":"Dalton Trans"},{"key":"10.1016\/j.nano.2013.10.002_bb0100","doi-asserted-by":"crossref","first-page":"6488","DOI":"10.1039\/c2dt11793b","article-title":"Polyanionic N-donor ligands as chelating agents in transition metal complexes: synthesis, structural characterization and antiviral properties against HIV","volume":"41","author":"Garcia-Gallego","year":"2012","journal-title":"Dalton Trans"},{"key":"10.1016\/j.nano.2013.10.002_bb0105","doi-asserted-by":"crossref","first-page":"939","DOI":"10.4103\/0971-5916.92639","article-title":"Microbicides: a new hope for HIV prevention","volume":"134","author":"Gupta","year":"2011","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.nano.2013.10.002_bb0110","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.antiviral.2011.03.186","article-title":"Virucidal activity of the dendrimer microbicide SPL7013 against HIV-1","volume":"90","author":"Telwatte","year":"2011","journal-title":"Antivir Res"},{"key":"10.1016\/j.nano.2013.10.002_bb0115","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jconrel.2012.04.050","article-title":"Carbosilane dendrimer nanotechnology outlines of the broad HIV blocker profile","volume":"161","author":"Chonco","year":"2012","journal-title":"J Control Rel"},{"key":"10.1016\/j.nano.2013.10.002_bb0120","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1128\/JVI.72.4.2855-2864.1998","article-title":"Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1","volume":"72","author":"Platt","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.nano.2013.10.002_bb0125","doi-asserted-by":"crossref","first-page":"5860","DOI":"10.1128\/JVI.02594-09","article-title":"Coinfection of hepatic cell lines with human immunodeficiency virus and hepatitis B virus leads to an increase in intracellular hepatitis B surface antigen","volume":"84","author":"Iser","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.nano.2013.10.002_bb0130","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1742-4690-6-27","article-title":"The Spanish HIV BioBank: a model of cooperative HIV research","volume":"6","author":"Garcia-Merino","year":"2009","journal-title":"Retrovirology"},{"key":"10.1016\/j.nano.2013.10.002_bb0135","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1089\/aid.2009.0122","article-title":"Pediatric HIV BioBank: a new role of the Spanish HIV BioBank in pediatric HIV research","volume":"26","author":"Garcia-Merino","year":"2010","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.nano.2013.10.002_bb0140","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1128\/JVI.59.2.284-291.1986","article-title":"Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone","volume":"59","author":"Adachi","year":"1986","journal-title":"J Virol"},{"key":"10.1016\/j.nano.2013.10.002_bb0145","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.1128\/JVI.69.6.3949-3954.1995","article-title":"Role of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infection","volume":"69","author":"Freed","year":"1995","journal-title":"J Virol"},{"key":"10.1016\/j.nano.2013.10.002_bb0150","doi-asserted-by":"crossref","first-page":"7517","DOI":"10.1128\/JVI.66.12.7517-7521.1992","article-title":"An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1","volume":"66","author":"Collman","year":"1992","journal-title":"J Virol"},{"key":"10.1016\/j.nano.2013.10.002_bb0155","doi-asserted-by":"crossref","first-page":"12733","DOI":"10.1039\/c2dt31099f","article-title":"Synthesis, structure and molecular modelling of anionic carbosilane dendrimers","volume":"41","author":"Rasines","year":"2012","journal-title":"Dalton Trans"},{"key":"10.1016\/j.nano.2013.10.002_bb0160","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.nano.2013.10.002_bb0165","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Adv Enzyme Regul"},{"key":"10.1016\/j.nano.2013.10.002_bb0170","doi-asserted-by":"crossref","first-page":"8749","DOI":"10.1016\/j.biomaterials.2010.07.093","article-title":"Phenotype and functional analysis of human monocytes-derived dendritic cells loaded with a carbosilane dendrimer","volume":"31","author":"Pion","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2013.10.002_bb0175","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s12038-009-0104-5","article-title":"Proteomic analysis of heparin-binding proteins from human seminal plasma: a step towards identification of molecular markers of male fertility","volume":"34","author":"Kumar","year":"2009","journal-title":"J Biosci"},{"key":"10.1016\/j.nano.2013.10.002_bb0180","first-page":"111","article-title":"Role of pH as a regulator of vaginal physiological environment","volume":"52","author":"Melis","year":"2000","journal-title":"Minerva Ginecol"},{"key":"10.1016\/j.nano.2013.10.002_bb0185","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/1471-2334-6-150","article-title":"Role of seminal plasma in the anti-HIV-1 activity of candidate microbicides","volume":"6","author":"Neurath","year":"2006","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.nano.2013.10.002_bb0260","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.idc.2007.01.009","article-title":"The future of HIV prevention: prospects for an effective anti-HIV microbicide","volume":"21","author":"Nuttall","year":"2007","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.nano.2013.10.002_bb0265","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1097\/QAD.0b013e32835e163d","article-title":"Currently available medications in resource-rich settings may not be sufficient for lifelong treatment of HIV","volume":"27","author":"Jansson","year":"2013","journal-title":"AIDS"},{"key":"10.1016\/j.nano.2013.10.002_bb0270","doi-asserted-by":"crossref","DOI":"10.1097\/QAD.0b013e328361fa4a","article-title":"Synergistic activity of carbosilane dendrimers in combination with maraviroc against HIV in vitro","author":"Cordoba","year":"2013","journal-title":"AIDS"},{"key":"10.1016\/j.nano.2013.10.002_bb0275","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1097\/QAD.0b013e32835f2b7a","article-title":"Development of sulphated and naphthylsulfonated carbosilane dendrimers as topical microbicides to prevent HIV-1 sexual transmission","volume":"27","author":"Cordoba","year":"2013","journal-title":"AIDS"},{"key":"10.1016\/j.nano.2013.10.002_bb0210","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1039\/C1NJ20396G","article-title":"Dendrimers as topical microbicides with activity against HIV","volume":"36","author":"Jim\u00e9nez","year":"2012","journal-title":"New J Chem"},{"key":"10.1016\/j.nano.2013.10.002_bb0215","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1128\/AAC.00976-10","article-title":"Combinatorial approaches to the prevention and treatment of HIV-1 infection","volume":"55","author":"Pirrone","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.nano.2013.10.002_bb0220","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1128\/AAC.49.9.3607-3615.2005","article-title":"Candidate sulfonated and sulfated topical microbicides: comparison of anti-human immunodeficiency virus activities and mechanisms of action","volume":"49","author":"Scordi-Bello","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.nano.2013.10.002_bb0225","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/QAI.0b013e31820a4a8d","article-title":"Combinations of 3-hydroxyphthalic anhydride-modified ovalbumin with antiretroviral drug-based microbicide candidates display synergistic and complementary effects against HIV-1 infection","volume":"56","author":"Li","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.nano.2013.10.002_bb0230","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2146\/ajhp080206","article-title":"Maraviroc: a coreceptor CCR5 antagonist for management of HIV infection","volume":"66","author":"Yost","year":"2009","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.nano.2013.10.002_bb0235","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1086\/655661","article-title":"Protection of rhesus macaques from vaginal infection by vaginally delivered maraviroc, an inhibitor of HIV-1 entry via the CCR5 co-receptor","volume":"202","author":"Veazey","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.nano.2013.10.002_bb0240","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1086\/600867","article-title":"Disruption of tight junctions by cellulose sulfate facilitates HIV infection: model of microbicide safety","volume":"200","author":"Mesquita","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.nano.2013.10.002_bb0245","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1056\/NEJMoa0707957","article-title":"Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission","volume":"359","author":"Van Damme","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nano.2013.10.002_bb0250","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/anie.200903924","article-title":"Thiol-ene click chemistry","volume":"49","author":"Hoyle","year":"2010","journal-title":"Angew Chem Int Ed Engl"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154996341300556X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154996341300556X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T00:00:42Z","timestamp":1596672042000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S154996341300556X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S154996341300556X"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2013.10.002","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]}}}